Understanding Semaglutide and GLP-1 Medications Semaglutide, sold under the names Ozempic (for type 2 diabetes) and Wegovy (for weight management), is a GLP-1 receptor agonist
Its main goal is to help lower blood sugar levels and reduce the risk of major cardiovascular events (like stroke or heart attack) in adults with Type 2 diabetes and known heart disease
Pregnancy Planning Women planning to become pregnant must stop Ozempic at least 2 months before attempting conception
mGluR2/3 blockade produces rapid and long-lasting reversal of anhedonia caused by chronic stress exposure
These check-ins allow your provider to monitor your progress, evaluate tolerability, and adjust dosing when medically appropriate
We work with major insurers like UnitedHealthcare, Cigna, Blue Cross Blue Shield, Aetna, Medicare Part D, and Medicaid, ensuring you can start your path to a healthier you without insurance hurdles